Pricing
Login
Home
Charts
Search
Watchlist
Products

Aarti Pharmalabs Ltd

AARTIPHARM
₹990.70-3.31%20 Nov 2026
Reports
Pharma API

Aarti Pharmalabs Ltd

AARTIPHARM
₹990.70
-3.31%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹8,984Cr
Close
Close Price
₹990.70
Industry
Industry
Pharma API
PE
Price To Earnings
34.99
PS
Price To Sales
4.16
Revenue
Revenue
₹2,161Cr
Rev Gr TTM
Revenue Growth TTM
13.38%
PAT Gr TTM
PAT Growth TTM
7.07%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
449506555458538564386418432583536610
Growth YoY
Revenue Growth YoY%
-4.94.321.24.219.911.5-30.5-8.7-19.63.438.745.9
Expenses
ExpensesCr
353388459364409418291344330470400475
Operating Profit
Operating ProfitCr
9611896941291469575102113136135
OPM
OPM%
21.323.217.420.423.925.824.717.923.719.425.422.1
Other Income
Other IncomeCr
12245-20-121485
Interest Expense
Interest ExpenseCr
455610771113171315
Depreciation
DepreciationCr
191920212323232529283031
PBT
PBTCr
749674721011156539638210195
Tax
TaxCr
213118172726161115212524
PAT
PATCr
536555557488502848617671
Growth YoY
PAT Growth YoY%
10.752.217.85.440.235.4-10.7-48.9-35.2-30.853.8156.0
NPM
NPM%
11.812.910.011.913.815.712.86.711.110.514.211.7
EPS
EPS₹
5.87.26.16.08.29.85.53.15.36.78.47.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
449506555458538564386418432583536610
Growth YoY
Revenue Growth YoY%
-4.94.321.24.219.911.5-30.5-8.7-19.63.438.745.9
Expenses
ExpensesCr
353388459364409418291344330470400475
Operating Profit
Operating ProfitCr
9611896941291469575102113136135
OPM
OPM%
21.323.217.420.423.925.824.717.923.719.425.422.1
Other Income
Other IncomeCr
12245-20-121485
Interest Expense
Interest ExpenseCr
455610771113171315
Depreciation
DepreciationCr
191920212323232529283031
PBT
PBTCr
749674721011156539638210195
Tax
TaxCr
213118172726161115212524
PAT
PATCr
536555557488502848617671
Growth YoY
PAT Growth YoY%
10.752.217.85.440.235.4-10.7-48.9-35.2-30.853.8156.0
NPM
NPM%
11.812.910.011.913.815.712.86.711.110.514.211.7
EPS
EPS₹
5.87.26.16.08.29.85.53.15.36.78.47.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
01,2001,9451,8532,1151,8192,161
Growth
Revenue Growth%
62.1-4.814.2-14.013.4
Expenses
ExpensesCr
09931,6031,4671,6511,4501,674
Operating Profit
Operating ProfitCr
0207342386464369487
OPM
OPM%
17.317.620.822.020.322.5
Other Income
Other IncomeCr
0325101528
Interest Expense
Interest ExpenseCr
0122117274757
Depreciation
DepreciationCr
042637387104117
PBT
PBTCr
0155261300361233341
Tax
TaxCr
0336784885884
PAT
PATCr
0122193217272175257
Growth
PAT Growth%
26,57,765.258.312.125.6-35.97.1
NPM
NPM%
10.29.911.712.99.611.9
EPS
EPS₹
-0.213.521.423.930.119.328.3
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
01,2001,9451,8532,1151,8192,161
Growth
Revenue Growth%
62.1-4.814.2-14.013.4
Expenses
ExpensesCr
09931,6031,4671,6511,4501,674
Operating Profit
Operating ProfitCr
0207342386464369487
OPM
OPM%
17.317.620.822.020.322.5
Other Income
Other IncomeCr
0325101528
Interest Expense
Interest ExpenseCr
0122117274757
Depreciation
DepreciationCr
042637387104117
PBT
PBTCr
0155261300361233341
Tax
TaxCr
0336784885884
PAT
PATCr
0122193217272175257
Growth
PAT Growth%
26,57,765.258.312.125.6-35.97.1
NPM
NPM%
10.29.911.712.99.611.9
EPS
EPS₹
-0.213.521.423.930.119.328.3
Sales CAGR
1 Year-14%
3 Years-2%
5 Years-
TTM13%
EBITDA CAGR
1 Year-20%
3 Years3%
5 Years-
TTM10%
PAT CAGR
1 Year-36%
3 Years-3%
5 Years-
TTM7%
Avg. ROCE
1 Year10%
3 Years14%
5 Years13%
TTM13%
CFO / EBITDA
1 Year71%
3 Years66%
5 Years57%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
004545454545
Reserves
ReservesCr
01,3411,5131,7121,9452,0792,209
Current Liabilities
Current LiabilitiesCr
05816016946579381,179
Non Current Liabilities
Non Current LiabilitiesCr
07385131259420392
Total Liabilities
Total LiabilitiesCr
02,0402,2442,5822,9063,4823,826
Current Assets
Current AssetsCr
01,0281,1631,3461,3221,3971,657
Non Current Assets
Non Current AssetsCr
01,0121,0811,2361,5842,0842,169
Total Assets
Total AssetsCr
02,0402,2442,5822,9063,4823,826
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
004545454545
Reserves
ReservesCr
01,3411,5131,7121,9452,0792,209
Current Liabilities
Current LiabilitiesCr
05816016946579381,179
Non Current Liabilities
Non Current LiabilitiesCr
07385131259420392
Total Liabilities
Total LiabilitiesCr
02,0402,2442,5822,9063,4823,826
Current Assets
Current AssetsCr
01,0281,1631,3461,3221,3971,657
Non Current Assets
Non Current AssetsCr
01,0121,0811,2361,5842,0842,169
Total Assets
Total AssetsCr
02,0402,2442,5822,9063,4823,826

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-44250216330262
Investing Cash Flow
Investing Cash FlowCr
0-139-158-215-412-431
Financing Cash Flow
Financing Cash FlowCr
0260-1631065171
Net Cash Flow
Net Cash FlowCr
078-7112-172
Free Cash Flow
Free Cash FlowCr
0-18514861-72-147
CFO To PAT
CFO To PAT%
0.0-35.8129.399.8121.2149.9
CFO To EBITDA
CFO To EBITDA%
0.0-21.173.156.071.170.9
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-44250216330262
Investing Cash Flow
Investing Cash FlowCr
0-139-158-215-412-431
Financing Cash Flow
Financing Cash FlowCr
0260-1631065171
Net Cash Flow
Net Cash FlowCr
078-7112-172
Free Cash Flow
Free Cash FlowCr
0-18514861-72-147
CFO To PAT
CFO To PAT%
0.0-35.8129.399.8121.2149.9
CFO To EBITDA
CFO To EBITDA%
0.0-21.173.156.071.170.9

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,4893,9426,7845,3428,984
Price To Earnings
Price To Earnings
12.918.224.930.635.0
Price To Sales
Price To Sales
1.32.13.22.94.2
Price To Book
Price To Book
1.62.23.42.54.0
EV To EBITDA
EV To EBITDA
7.910.915.516.520.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.731.234.136.837.137.1
OPM
OPM%
17.317.620.822.020.322.5
NPM
NPM%
10.29.911.712.99.611.9
ROCE
ROCE%
-1.910.015.915.616.19.712.9
ROE
ROE%
-2.09.112.412.313.78.211.4
ROA
ROA%
-1.86.08.68.49.45.06.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,4893,9426,7845,3428,984
Price To Earnings
Price To Earnings
12.918.224.930.635.0
Price To Sales
Price To Sales
1.32.13.22.94.2
Price To Book
Price To Book
1.62.23.42.54.0
EV To EBITDA
EV To EBITDA
7.910.915.516.520.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.731.234.136.837.137.1
OPM
OPM%
17.317.620.822.020.322.5
NPM
NPM%
10.29.911.712.99.611.9
ROCE
ROCE%
-1.910.015.915.616.19.712.9
ROE
ROE%
-2.09.112.412.313.78.211.4
ROA
ROA%
-1.86.08.68.49.45.06.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr16,60811,47010,2728,9845,7515,4044,991
Close PriceClose₹849.15548.201,598.60990.70960.40184.12620.15
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE49.9541.0375.8034.99134.7026.6128.18
Price To SalesPS9.029.8011.824.164.711.965.68
RevenueRevenueCr1,8421,1708692,1611,2212,751879
Revenue Growth TTMRev Gr TTM%37.3%4.0%13.4%20.1%26.8%23.0%
PAT Growth TTMPAT Gr TTM%142.2%-13.6%7.1%16.5%75.4%-2.8%
Market CapitalizationMkt CapCr16,60811,47010,2728,9845,7515,4044,991
Close PriceClose₹849.15548.201,598.60990.70960.40184.12620.15
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE49.9541.0375.8034.99134.7026.6128.18
Price To SalesPS9.029.8011.824.164.711.965.68
RevenueRevenueCr1,8421,1708692,1611,2212,751879
Revenue Growth TTMRev Gr TTM%37.3%4.0%13.4%20.1%26.8%23.0%
PAT Growth TTMPAT Gr TTM%142.2%-13.6%7.1%16.5%75.4%-2.8%